KJIM :: Korean Journal of Internal Medicine

Generic substitution of amlodipine is not associated with increased risk of mortality or adverse cardiovascular events: An observational cohort study

Clinical and Translational Science.2024;[Epub] CrossRef

Pharmacoeconomic evaluation of stroke and myocardial infarction prevention in hypertensive patients: Markov model based on the ACCOMPLISH trial

Aozi Feng, Weizhao Lin, Li Li, Mengnan Zeng, Jun Lyu

Journal of International Medical Research.2023;[Epub] CrossRef

A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine

Jamshed Dalal, J. P. Sawhney, P. B. Jayagopal, P. K. Hazra, Mohammed Yunus Khan, Kumar Gaurav, Colette Pinto, Amey Mane, Sachin Rao, Madhur Jain, Tomohiro Katsuya

International Journal of Hypertension.2022; 2022: 1. CrossRef

Study of potential interactions of oral antidiabetic drugs in patients with type 2 diabetes mellitus with comorbidities: A retrospective study

Big Challenge in Big Data Research: Continual Dispute on Big Data Analysis

Korean Circulation Journal.2020; 50(1): 69. CrossRef

Appraisal of disease-modifying potential of amlodipine as an anti-arthritic agent: new indication for an old drug

Sumera Qasim, Alamgeer, Saima Kalsoom, Muhammad Shahzad, Hafiz Muhammad Irfan, Muhammad Shoaib Zafar, Ishfaq Ali Bukhari, Fahim Vohra, Sibtain Afzal

Inflammopharmacology.2020; 28(4): 1121. CrossRef

Effectiveness of Amlodipine on Blood Pressure Control in Hypertensive Patients in India: A Real-World, Retrospective Study from Electronic Medical Records

Mohammed Yunus Khan, Sucheta Pandit, Saumitra Ray, Jagdish Chander Mohan, B. C. Srinivas, Santosh Ramakrishnan, Amey Mane, Suyog Mehta, Snehal Shah

Drugs - Real World Outcomes.2020; 7(4): 281. CrossRef

Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50

Simon B. Dimmitt, Hans G. Stampfer, Jennifer H. Martin, Robin E. Ferner

British Journal of Clinical Pharmacology.2019; 85(10): 2218. CrossRef

Therapeutic approach to dyslipidemias, the main cause of atherosclerosis

Medication Adherence Improvement By Using Administration Timing Simplification Protocol (ATSP) in Cardiovascular Disease Patients

Sun Hoi Jung, Ok Sang Lee, Hyang Sook Kim, Chan Soon Park, Hyun Jung Lee, Kyeng Hee Kwon, Hae Young Lee

Journal of Atherosclerosis and Thrombosis.2017; 24(8): 841. CrossRef

A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia

Hae-Young Lee, Seok-Yeon Kim, Kee-Joon Choi, Byung-Su Yoo, Dong-Hun Cha, Hae Ok Jung, Dong-Ryeol Ryu, Joon Hyouk Choi, Kwang Je Lee, Tae Ho Park, Ju Hyeon Oh, Sang Min Kim, Ji-Yong Choi, Kye Hun Kim, Jaemin Shim, Woo-Shik Kim, Si-Wan Choi, Dae-Gyun Park,

Clinical Therapeutics.2017; 39(12): 2366. CrossRef

Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients – thinking of clinically relevant CYP2D6 interactions

Michael Paulzen, Ekkehard Haen, Gerhard Gründer, Sarah E Lammertz, Benedikt Stegmann, Koen RJ Schruers, Sebastian Walther, Georgios Schoretsanitis

Journal of Psychopharmacology.2016; 30(8): 803. CrossRef

Antihypertensive and pleiotropic activity of the calcium antagonist amlodipine in patients with arterial hypertension and obesity

M. G Bubnova, D. M Aronov, I. V Kuznetsova, V. A Vygodin

The results of the pharmacoepidemiological study PIFAGOR IV concerning arterial hypertension (AH patients survey)

M V Leonova, Yu B Belousov, L L Shteinberg, E E Alimova, E P Smirnova, D Yu Belousov

Is amlodipine more cardioprotective than other antihypertensive drug classes?

The Korean Journal of Internal Medicine.2014; 29(3): 301. CrossRef

The role of amlodipine (norvasc) in Cardiology